marginally significantp < 0.01
At 2-month follow-up, the tACS treatment group did show a marginally significant decrease in AHRS with an effect size of 0.450 ( p < 0.01, 95% upper bound = 0.10) comparable to our previous study 49 .
At 2-month follow-up, the tACS treatment group did show a marginally significant decrease in AHRS with an effect size of 0.450 ( p < 0.01, 95% upper bound = 0.10) comparable to our previous study 49 .